Functional status in patients undergoing lung resection-Reference-Cited by-同舟云学术

Functional status in patients undergoing lung resection

Published:2024-07-30 Issue: Volume: Page:
ISSN:1734-1922
Container-title:Archives of Medical Science
language:
Short-container-title:Arch Med Sci

Author:

Macounová Petra¹^ORCID,Bobčíková Katka²^ORCID,Tomášková Hana¹^ORCID,Mitták Marcel³,Argalášová Ľubica⁴

Affiliation:

1. Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

2. Department of Nursing and Midwifery, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

3. Department of Surgery, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic

4. Institute of Hygiene, Faculty of Medicine, Comenius University in Bratislava, Slovak Republic

Abstract

IntroductionThis prospective study aimed to evaluate the functional status and risk factors in patients undergoing lung resection.MethodsFunctional status defined by the parameters of spirometry (VC, FVC, FEV1, FEV1/FVC) and whole-body plethysmography (TLC) examination was assessed before lung resection, at hospital discharge, 3 weeks after surgery, and 3 months after surgery.ResultsThe sample comprised 24 participants who were observed from 5/2021 to 10/2022. The functional status worsened significantly after the surgery, but the lung function values improved over time.ConclusionsLung functions dropped sharply after the surgery but improved over time.

Publisher

Termedia Sp. z.o.o.

Link

https://www.archivesofmedicalscience.com/pdf-190516-112839

Reference32 articles.

1. Simanek V, Klecka J, Treska V, Pesek M, Bednárová V. [Combined procedure of pulmonary resection and radiofrequency ablation of lung tumours – case reports]. Rozhl Chir 2013; 92: 205-8.

2. Peters BA, Pass HI, Burk RD, et al. The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer. Genome Med 2022; 14: 121.

3. Doerr F, Stange S, Michel M, et al. Stage I and II small-cell lung cancer – new challenge for surgery. Lung 2022; 200: 505-12.

4. Mitchell KG, Farooqi A, Ludmir EB, et al. Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer. J Thorac Cardiovasc Surg 2021; 161: 1497-504.

5. Jhala H, Harling L, Rodrigo A, et al. Clinicopathological predictors of survival in resected primary lung adenocarcinoma. J Clin Pathol 2022; 75: 310-5.